NRx Pharmaceuticals, Inc. B1QB.F Stock
NRx Pharmaceuticals, Inc. Price Chart
NRx Pharmaceuticals, Inc. B1QB.F Financial and Trading Overview
| NRx Pharmaceuticals, Inc. stock price | 0.49 EUR |
| Previous Close | 0.49 EUR |
| Open | 0.49 EUR |
| Bid | 0.48 EUR x N/A |
| Ask | 0.49 EUR x N/A |
| Day's Range | 0.49 - 0.49 EUR |
| 52 Week Range | 0.47 - 1.46 EUR |
| Volume | 500 EUR |
| Avg. Volume | 937 EUR |
| Market Cap | 34.72M EUR |
| Beta (5Y Monthly) | 0.956338 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
B1QB.F Valuation Measures
| Enterprise Value | 30.34M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.797 |
Trading Information
NRx Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 0.956338 |
| 52-Week Change | 5.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.46 EUR |
| 52 Week Low | 0.47 EUR |
| 50-Day Moving Average | 0.58 EUR |
| 200-Day Moving Average | 0.83 EUR |
B1QB.F Share Statistics
| Avg. Volume (3 month) | 937 EUR |
| Avg. Daily Volume (10-Days) | 2.12K EUR |
| Shares Outstanding | 70.31M |
| Float | 44.79M |
| Short Ratio | N/A |
| % Held by Insiders | 39.16% |
| % Held by Institutions | 4.50% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -72.77% |
| Return on Equity (ttm) | -237.82% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -38061000 EUR |
| Net Income Avi to Common (ttm) | -37345000 EUR |
| Diluted EPS (ttm) | -0.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.51M EUR |
| Total Cash Per Share (mrq) | 0.24 EUR |
| Total Debt (mrq) | 12.19M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.986 |
| Book Value Per Share (mrq) | -0.004 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -35464000 EUR |
| Levered Free Cash Flow (ttm) | -24193624 EUR |
Profile of NRx Pharmaceuticals, Inc.
| Country | Germany |
| State | DE |
| City | Wilmington |
| Address | 1201 Orange Street |
| ZIP | 19801 |
| Phone | (484) 254-6134 |
| Website | https://www.nrxpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics that is in phase IIb/III clinical trials for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Q&A For NRx Pharmaceuticals, Inc. Stock
What is a current B1QB.F stock price?
NRx Pharmaceuticals, Inc. B1QB.F stock price today per share is 0.49 EUR.
How to purchase NRx Pharmaceuticals, Inc. stock?
You can buy B1QB.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NRx Pharmaceuticals, Inc.?
The stock symbol or ticker of NRx Pharmaceuticals, Inc. is B1QB.F.
Which industry does the NRx Pharmaceuticals, Inc. company belong to?
The NRx Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does NRx Pharmaceuticals, Inc. have in circulation?
The max supply of NRx Pharmaceuticals, Inc. shares is 9.57M.
What is NRx Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
NRx Pharmaceuticals, Inc. PE Ratio is 0.00000000 now.
What was NRx Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
NRx Pharmaceuticals, Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the NRx Pharmaceuticals, Inc. company belong to?
The NRx Pharmaceuticals, Inc. sector is Healthcare.